Interleukin-2 (IL-2)-dependent T cell clone CTLL-2 underwent apoptosis by deprivation of IL-2 from culture medium. The decrease in the anti-apoptotic Bcl-X L protein level was observed during apoptosis after IL-2 withdrawal. We found that Bcl-X L protein was cleaved to produce two 18 kDa fragments during CTLL-2 cell apoptosis. When the activation of caspases was suppressed by overexpressing human Bcl-2 protein or by the addition of caspase inhibitors, cleavage of Bcl-X L protein was suppressed in vivo. Bcl-X L protein cleavage by incubation with apoptosed CTLL-2 cell lysate was suppressed by the caspase-3/CPP32-speci®c tetrapeptide inhibitor in vitro. Therefore, caspase-3/CPP32-like proteases were activated and involved in the cleavage of Bcl-X L protein during CTLL-2 cell apoptosis. We found that Bcl-X L protein was cleaved by caspase-3/ CPP32 at two sites in the loop domain (i.e., HLAD A). The transfection of the carboxy-terminal 18 kDa Bcl-X L fragment increased the sensitivity to apoptosis. These results indicate that caspase-3/CPP32-like proteases cleaved anti-apoptotic Bcl-X L protein and resulted in accelerated apoptotic cell death.
Introduction
Genetic analyses of apoptosis in Caenorhabditis elegans revealed the anti-apoptotic gene ced-9 (Hengartner et al., 1992) . The proto-oncogene bcl-2 had homology with ced-9 (Hengartner and Horvitz, 1994) . The bcl-2 gene was originally isolated from the t(14;18) chromosomal breakpoint in follicular B-lymphoma cells (Tsujimoto et al., 1985) . The bcl-2 has been shown to prevent apoptosis of certain haematopoietic cell lines induced by growth-factor deprivation (Hockenbery et al., 1990) . Identi®cation of bcl-2 homologs revealed two types in the family protein (Boise et al., 1995; Craig, 1995) . Bcl-2, Bcl-X L , Bcl-w, B¯-l, A1, Mcl-1 and Bag-1 were known to suppress apoptosis. However, Bax, Bcl-X S , Bak, Bid, Hrk and Bad were known to act as death agonists (Kroemer, 1997) . These death antagonists and agonists of Bcl-2 family proteins could form heterodimers with each other (Yang and Korsmeyer, 1996) . Therefore, these protein-protein interactions are believed to regulate the protective and promotive eects of the proteins during apoptosis.
The ced-3 gene was also identi®ed by genetic analyses of apoptosis in C. elegans. The mutation of the ced-3 gene prevented apoptosis during normal development of C. elegans (Ellis and Horvitz, 1986; Yuan and Horvitz, 1990) . The mammalian homolog of ced-3 was identi®ed as caspase-1/interleukin-1b-converting enzyme (ICE) . Several ICE homologs (caspases) (Alnemri et al., 1996) were also identi®ed (Henkart, 1996) . These caspases were certainly involved in driving apoptosis because their overexpression could induce apoptosis, and some potent inhibitors of caspases could suppress apoptosis induced by various stimuli, such as an anti-Fas mAb, tumor necrosis factor, and anti-cancer drugs (Miura et al., 1993; Enari et al., 1995; Los et al., 1995; Mashima et al., 1995) . Several investigators have suggested that the protease cascade was involved in the transduction of death signals (Enari et al., 1995; Los et al., 1995) such that the activated caspase-4/Ich-2/TX/ICErel-II cleaves the precursor form of caspase-1/ICE to generate the mature form (Faucheu et al., 1995) , and the activated caspase-1/ICE cleaves zymogen of caspase-3/CPP32/Yama/Apopain to produce the active form (Tewari et al., 1995) in vitro.
Death-suppressor Bcl-2 and Bcl-X L proteins were found to suppress the activation of caspases (Armstrong et al., 1996; Boulakia et al., 1996; Chinnaiyan et al., 1996; Shimizu et al., 1996) . Recently, Bcl-2 and Bcl-X L were found to inhibit the release of cytochrome c, which was associated with the activation of caspase-3/CPP32, from mitochondria (Kharbanda et al., 1997; Kim et al., 1997; Kluck et al., 1997; Yang et al., 1997) . Therefore, the deathsuppressor Bcl-2 family proteins might function upstream of the caspases.
In the course of examining the CTLL-2 cell apoptosis, we found that the Bcl-X L protein was cleaved and that the caspase-3/CPP32-like proteases were involved in the cleavage. We found that Bcl-X L protein was cleaved after HLAD 61 and SSLD 76 sequences in the loop domain. As the transfection of the NH 2 terminal-truncated Bcl-X L fragment increased the sensitivity to apoptosis, caspase-3/CPP32-like proteases cleaved anti-apoptotic Bcl-X L protein, which in turn resulted in caspase activation and apoptotic cell death ampli®cation. culture medium, CTLL-2 cells underwent apoptosis with nuclear ( Figure 1b ) and chromosomal DNA ( Figure 1c , lanes 2 and 3) fragmentations in a timedependent manner (Duke and Cohen, 1986) . However, CTLL-2 cells evaded apoptosis when IL-2 was supplemented in the culture medium (Figure 1a and c) .
We ®rst examined by Western blot analysis the changes of Bcl-2 family protein expression during CTLL-2 cell apoptosis. CTLL-2 cells did not undergo apoptosis when they were cultured without IL-2 for 6 h, and the expression level of Bcl-X L protein was similar ( Figure 2 , lane 2). However, the expression level of Bcl-X L protein was reduced when CTLL-2 cells were cultured for 24 h without IL-2 (Figure 2 , lane 3, upper arrow), as reported previously (Broome et al., 1995) . We found two additional bands (&18 kDa) that were cross-reactive to the anti-mouse Bcl-X-speci®c monoclonal antibody (mAb) in the apoptosed CTLL-2 cell lysates ( Figure 2 , lane 3, lower arrows). This type of additional bands did not appear in the cell lysates of CTLL-2 cells cultured in the IL-2-supplemented medium (Figure 2, lanes 4 and 5) . The expression levels of Bcl-2, Bag-1 and Bax proteins were not changed regardless of whether CTLL-2 cells underwent apoptosis or not (Figure 2 and data not shown).
When CTLL-2 cells were treated with VP-16 (etoposide) at 10 mg/ml, CTLL-2 underwent apoptosis with DNA fragmentation within 6 h ( Figure 3a , lanes 2 and 3). We could detect two similar additional bands in the VP-16-treated CTLL-2 cell lysates ( Figure 3b , lanes 2 and 3). The VP16-mediated apoptosis and the appearance of the 18 kDa fragments were partially suppressed by the addition of IL-2 into the culture medium ( Figure 3a and b, lane 2). Therefore, the appearance of 18 kDa fragments was closely related to the level of apoptosis in CTLL-2 cells.
Activation of capase-3/CPP32-like proteases during apoptotic cell death in CTLL-2 cells When apoptosed CTLL-2 lysates were incubated in vitro, the expression level of 18 kDa fragments was slightly increased (data not shown). This result indicates that some proteases contained in the apoptosed CTLL-2 lysates were involved in the cleavage of the Bcl-X L protein to produce the 18 kDa fragments. Recent works revealed that the caspases were activated during CTLL-2 cell apoptosis (Ohta et al., 1997) . To assess the role of caspases in this apoptosis, we ®rst examined their activity using¯uorogenic-labeled tetrapeptides, acetyl-
When the apoptosed CTLL-2 cell lysates were incubated for 1 h with these¯uorogenic substrates, the AMC was Figure 1 Induction of apoptosis in CTLL-2 cells by deprivation of IL-2 from the culture media. (a and b) CTLL-2 cells were cultured for 24 h with (a) or without (b) IL-2. After ®xation with methanol/acetate (3 : 1), cells were stained with DAPI, as described in Materials and methods. (c) CTLL-2 cells were harvested (0 h; lane 1) and were incubated with medium alone (lanes 2 and 3) or IL-2-supplemented medium (lanes 4 and 5) for 10 h (lanes 2 and 4) or 24 h (lanes 3 and 5). Then the DNA was isolated from each sample and electrophoresed in a 2% agarose gel plate. The molecular size marker was the 100 bp DNA ladder (lane M) Figure 2 Expression of Bcl-2 family proteins during CTLL-2 cell apoptosis. CTLL-2 cells were harvested (0 h; lane 1) and were incubated with medium alone (lanes 2 and 3) or IL-2-supplemented medium (lanes 4 and 5) for 6 h (lanes 2 and 4) or 24 h (lanes 3 and 5). The cell lysates (20 mg/lane) were electrophoresed and blotted onto a nitrocellulose membrane, as described in Materials and methods. The membrane was incubated with an anti-mouse Bcl-X-speci®c mAb, an anti-mouse Bcl-2-speci®c mAb, or an anti-mouse Bag-1-speci®c pAb for 2 h. After washing, the membranes were incubated with a peroxidaseconjugated second antibody and developed with ECL mixture Figure 3 Induction of apoptosis in CTLL-2 cells by VP-16. CTLL-2 cells were harvested and cultured with (lanes 2 and 3) or without (lanes 1 and 4) 10 mg/ml of VP-16 in the presence (lanes 1 and 2) or the absence (lanes 3 and 4) of IL-2 for 6 h. (a) The DNA was isolated from each sample and electrophoresed in a 2% agarose gel plate. The molecular size marker was the 100 bp DNA ladder (lane M). (b) The cell lysates (20 mg/lane) were electrophoresed and blotted onto a nitrocellulose membrane, as described in Materials and methods. The membrane was incubated with an anti-mouse Bcl-X-speci®c mAb. After washing, the membranes were incubated with a peroxidase-conjugated second antibody and developed with ECL mixture Figure 4 Suppression of CTLL-2 cell apoptosis and Bcl-X L protein cleavage by caspase inhibitors. (a and b) CTLL-2 cells were harvested and washed twice with PBS. Then CTLL-2 cells were cultured with (+1L-2) or without (7IL-2) IL-2 for 20 h. When CTLL-2 cells were cultured with 100 mg/ml of Z-Asp-CH 2 -DCB, cells were cultured in the IL-2-depleted medium for 20 h. The cell lysates were incubated with YVAD-AMC (a) or DEVD-AMC (b) for 1 h at 378C. The AMC liberated from the¯uorogenic substrates was measured, as described in Materials and methods. The vertical bars represent SD values of triplicate determinations. (c) CTLL-2 cells were cultured with medium alone (control) or medium containing the indicated concentrations of Z-Asp-CH 2 -DCB or 100 mg/ml of Z-VAD in the IL-2-depleted culture medium. After a 20 h culture, the viable cell numbers were counted using the trypan blue dye exclusion method. The vertical bars represent SD values of triplicate determinations. (d) CTLL-2 cells were cultured in IL-2-supplemented medium (lane 1) or in IL-2-depleted medium (lane 2). CTLL-2 cells were cultured with 100 mg/ml of Z-Asp-CH 2 -DCB in the IL-2-depleted medium (lane 3). After cultivation for 20 h, 20 mg of the cell lysates were electrophoresed and blotted onto a nitrocellulose membrane, as described in Materials and methods. The membrane was incubated with an anti-mouse Bcl-X-speci®c mAb or an anti-mouse Bcl-2-speci®c mAb for 2 h. After washing, the membranes were incubated with a peroxidaseconjugated second antibody and developed with ECL mixture liberated from DEVD-AMC but not from YVAD-AMC (Figure 4a and b) . When CTLL-2 cells were cultured in IL-2-supplemented medium, the CTLL-2 cell lysates did not show caspase activity that could cleave DEVD-AMC. The cultivation of CTLL-2 cells with the previously reported caspase inhibitor, benzyloxycarbonyl-Asp-CH 2 O)C(O)-2,6-dichlorobenzene (ZAsp-CH 2 -DCB) (Mashima et al., 1995) , also suppressed caspase activity in the lysates (Figure 4b ). These results indicate that caspase-3/CPP32-like proteases that cleave DEVD-AMC are activated during CTLL-2 cell apoptosis.
When CTLL-2 cells were cultured with Z-Asp-CH 2 -DCB, CTLL-2 cells evaded apoptosis in a dosedependent manner (Figure 4c ). Adding other inhibitors to the caspases (e.g., Z-Val-Ala-Asp-CH 2 -DCB; Z-VAD and Z-Glu-Val-Asp-CH 2 -DCB; Z-EVD) also suppressed apoptosis (Figure 4c and data not shown). These results indicate that the activation of caspase-3/ CPP32-like proteases is involved in promoting CTLL-2 cell apoptosis.
When CTLL-2 cells were cultured with Z-Asp-CH 2 -DCB in the absence of IL-2, they did not undergo apoptosis ( Figure 4c ). Under this condition, we could not detect the two additional bands that were crossreactive to the anti-mouse Bcl-X mAb ( Figure 4d , lane 3). Adding Z-VAD or Z-EVD to the culture medium also suppressed the appearance of the 18 kDa fragments (data not shown). These results indicate that Bcl-X L protein is cleaved and thus produces 18 kDa fragments by caspases-3/CPP32-like proteases.
Suppression of CTLL-2 cell apoptosis and the cleavage of Bcl-X L protein by overexpressing human Bcl-2 protein
The overexpression of Bcl-2 protein is known to suppress the CTLL-2 cell apoptosis induced by IL-2 deprivation through functionally masking the drop of , and human bcl-2 cDNA transfectant DB-10 (lane 3) cells were cultured in IL-2-supplemented medium. Twenty rnicrograms of the cell lysates were electrophoresed and blotted onto a nitrocellulose membrane, as described in Materials and methods. The membrane was incubated with an anti-human Bcl-2-speci®c mAb, an antimouse Bcl-2-speci®c mAb, an anti-mouse Bcl-X-speci®c mAb, or an anti-mouse Bag-1-speci®c pAb for 2 h. After washing, the membranes were incubated with a peroxidase-conjugated second antibody and developed with ECL mixture. (b) CTLL-2 (lanes 1 and 2), DM-5 (lanes 3 and 4), and DB-10 (lanes 5 and 6) cells were cultured with (lanes 1, 3, and 5) or without (lanes 2, 4, and 6) IL-2 for 24 h. The DNA was isolated from each sample and electrophoresed in a 2% agarose gel plate. The molecular size marker was the 100 bp DNA ladder (lane M). (c) DM-5 and DB-10 cells were cultured with or without IL-2 for 24 h. The cell lysates were incubated with DEVD-AMC for 1 h at 378C. The AMC liberated from the¯uorogenic substrates was measured, as described in Materials and methods. The vertical bars represent s.d. values of triplicate determinations. (d) CTLL-2 (lanes 1 and 2), DM-5 (lanes 3 and 4), and DB-10 (lanes 5 and 6) cells were cultured with (lanes 1, 3 and 5) or without (lanes 2, 4 and 6) IL-2 for 24 h. Twenty micrograms of the cell lysates were electrophoresed and blotted onto a nitrocellulose membrane, as described in Materials and methods. The membrane was incubated with an anti-mouse Bcl-X-speci®c mAb or an anti-mouse Bcl-2-speci®c mAb for 2 h. After washing, the membranes were incubated with a peroxidase-conjugated second antibody and developed with ECL mixture Bcl-X L expression (Broome et al., 1995) . Therefore, we tried to establish CTLL-2 cells that were overexpressed human Bcl-2 (hBcl-2) protein to estimate the eect of Bcl-2 on the caspase activity. We established several hbcl-2 cDNA transfectants (e.g., DB-10) and mock transfectants (e.g., DM-5). DB-10 cells stably overexpressed the hBcl-2 protein (Figure 5a, lane 3) . The steady-state levels of endogenous mouse Bcl-2 (mBcl-2), mBcl-X L and mBag-1 proteins were not changed among transfectants and parental CTLL-2 cells (Figure 5a ).
The parental CTLL-2 cells and the mock-transfectant DM-5 cells underwent apoptosis with DNA fragmentation after IL-2 withdrawal (Figure 5b , lanes 2 and 4, respectively). However, DB-10 cells evaded apoptosis (Figure 5b , lane 6). We saw that during the examination of caspase activity using the¯uorogenic substrate of caspase-3/CPP32-like proteases (DEVD-AMC) the AMC was liberated in DM-5 cells but not in DB-10 cells that were cultured without IL-2 ( Figure  5c ). These results indicate that overexpression of hBcl-2 protein suppresses the apoptosis of CTLL-2 cells by inhibiting the activation of caspase-3/CPP32-like proteases.
Using these transfectants, we examined the appearance of 18 kDa fragments after IL-2 withdrawal. Under these conditions, DB-10 cells did not produce 18 kDa fragments, even when cultured for 24 h ( Figure  5d , lane 6). These results again indicate that caspase-3/ CPP32-like proteases are involved in the proteolytic cleavage of Bcl-X L protein.
Determination of the cleavage site in Bcl-X L protein
To con®rm that Bcl-X L protein was cleaved to produce 18 kDa fragments, a pcDNA3 vector containing Xpress epitope-tagged mouse bcl-X L was used for direct transcription/translation in reticulocyte lysates, and the resulting 35 S-methionine-labeled Bcl-X L protein was incubated with apoptosed CTLL-2 lysates. The 34 kDa Xpress epitope-tagged Bcl-X L protein was cleaved to produce a single 18 kDa fragment ( Figure  6a , lane 3). The 18 kDa Bcl-X L fragment observed in Figure 6a was identical to the upper band (larger fragment) observed in vivo (Figures 2 ± 5 ). The cleavage was suppressed by the addition of a tetrapeptide inhibitor of caspase-3/CPP32-like proteases (acetyl-DEVD aldehyde; DEVD-CHO) but not by a tetrapeptide inhibitor of caspase-1/ICE-like proteases (acetyl-YVAD aldehyde; YVAD-CHO) and aprotinin ( Figure  6a ). Therefore, Bcl-X L protein was cleaved by the caspase-3/CPP32-like proteases contained in the apoptosed CTLL-2 lysates.
When 35 S-methionine-labeled Bcl-X L protein was incubated with active recombinant human caspase-3/ CPP32, Bcl-X L protein was cleaved by caspase-3/ CPP32 in a dose-dependent manner and produced two 18 kDa fragments (Figure 6b ) of the same size (&18 kDa) observed in vivo (Figures 2 ± 5) . Therefore, Bcl-X L protein was one of the substrates of caspase-3/ CPP32. Recently, several investigators reported that Bcl-2 protein was also cleaved by caspase-3/CPP32 (Cheng et al., 1997; Grandgirard et al., 1998) . Thus, a pcDNA3 vector containing mouse bcl-2 was used for direct transcription/translation in reticulocyte lysates, and the resulting 35 S-methionine-labeled Bcl-2 protein was incubated with active recombinant human caspase-3/CPP32. Consistent with previous reports, Bcl-2 protein was cleaved by caspase-3/CPP32 in a dosedependent manner and produced a single 23 kDa fragment (Figure 6c ). Although both Bcl-X L and Bcl-2 proteins were cleaved by caspase-3/CPP32, Bcl-X L protein was more susceptible to caspase-3/CPP32 digestion.
We then tried to identify the cleavage sites in Bcl-X L protein by constructing several bcl-X L mutant cDNAs in which aspartic acid codon at 61, 76, 95 or 107 were converted to alanine codon (D61A, D76A, D95A or D107A, respectively). The mutant proteins were produced by direct transcription/translation in reticulocyte lysates and were incubated with apoptosed CTLL-2 lysates. The D61A mutant protein was not cleaved even when it was incubated with apoptosed CTLL-2 lysate (Figure 7a, lane 4) . Other mutant proteins were cleaved to produce the larger 18 kDa Bcl-X L fragment when they were incubated with Figure 6 The cleavage of Bcl-X L protein by caspase-3/CPP32 in vitro. (a) The Xpress epitope-tagged wild-type mouse Bcl-X L protein was labeled with 35 S-methionine using a rabbit reticulocyte lysate system (lane 1). The in vitro translated reticulocyte lysate was incubated with 25 mg of apoptosed CTLL-2 cytosol fraction (lane 3) in the presence of YVAD-CHO (100 nM; lane 4), DEVD-CHO (100 nM; lane 5), or aprotinin (2 mg/ml; lane 6) for 4 h at 378C. The CTLL-2 cytosol fraction without reticulocyte lysate was also incubated (lane 2). The reactions were applied to a 15 ± 25% gradient polyacrylamide gel, followed by autoradiography. Repeated experiments gave similar results. (b and c) The in vitro translated reticulocyte lysates containing Xpress epitope-tagged wild-type mouse Bcl-X L protein (b) and wild-type mouse Bcl-2 protein (c) were incubated with 10, 2, 0.4, 0.08 and 0.016 mg/ml of active recombinant human caspase-3/CPP32 (lanes 1 ± 5, respectively) for 4 h at 378C. The reactions were applied to a 15 ± 25% gradient polyacrylamide gel, followed by autoradiography. Repeated experiments gave similar results apoptosed CTLL-2 lysates (Figure 7a ). To identify another cleavage site that was associated with the production of smaller 18 kDa Bcl-X L fragment, the mutant proteins were incubated with active recombinant human caspase-3/CPP32 (Figure 7b ). The D76A mutant protein was cleaved to produce the larger fragment but did not produce the smaller fragment (Figure 7b, lane 6) . Because the D61A mutant protein was not cleaved to produce the larger fragment ( Figure  7b, lane 4) A) by caspase-3/CPP32.
Acceleration of apoptosis by the cleaved Bcl-X L fragment
We investigated the function of the cleaved Bcl-X L fragment, i.e., the NH 2 terminal-truncated form of the Bcl-X L protein (DN-Bcl-X L protein; amino acids 62 ± 233). We tried to establish the DN-bcl-X L cDNAtransfected CTLL-2 cells. Although we could establish many transfectants that overexpressed wild-type Bcl-X L protein, we could not obtain the transfectants that overexpressed DN-Bcl-X L protein (data not shown).
The overexpression of DN-Bcl-X L protein might be lethal in CTLL-2 cells. Then, pcDNA3 vectors containing Xpress-tagged DN-bcl-X L and wild-type bcl-X L were transfected, and they transiently expressed in 293T cells. Using an anti-mouse Bcl-X-speci®c mAb, we con®rmed the expression of Xpress-tagged wild-type Bcl-X L and DN-Bcl-X L proteins in 293T cells ( Figure   8a ). Using an anti-Xpress mAb, we obtained similar results (data not shown).
The transfected 293T cells were stimulated to undergo apoptosis by treatment with the anti-cancer Figure 7 Identi®cation of the cleavage sites in Bcl-X L protein.
The in vitro translated reticulocyte lysates containing Xpress epitope-tagged wild-type Bcl-X L protein (lanes 1 and 2), D61A mutant protein (lanes 3 and 4), D76A mutant protein (lanes 5 and 6), D95A mutant protein (lanes 7 and 8), or D107A mutant protein (lanes 9 and 10) were incubated with 25 mg of apoptosed CTLL-2 cytosol fraction (a) or 10 mg/ml of active recombinant human caspase-3/CPP32 (b) for 4 h at 378C. The reactions were applied to a 15 ± 25% gradient polyacrylamide gel, followed by autoradiography. Repeated experiments gave similar results drug VP-16. We detected the apoptotic 293T cells using FITC-labeled annexin V, which speci®cally binds to phosphatidylserine in the presence of Ca 2+ (Koopman et al., 1994) . Phosphatidylserine was known to translocate from the inner side of the plasma membrane during apoptosis (Fadok et al., 1992) . The overexpression of wild-type Bcl-X L and DN-Bcl-X L proteins did not aect the viability of 293T cells within 48 h (Figure 8b and c, closed areas) . Treating 293T cells with 20 mg/ml of VP-16 increased the number of annexin V-positive cell fractions by transfection with DN-bcl-X L (Figure 8c , open area) rather than by transfection with mock and wild-type bcl-X L (data not shown and Figure 8b , open area). These results indicate that the cleaved Bcl-X L fragment (DN-Bcl-X L protein) increases the sensitivity to apoptosis (Figure 9 ).
Discussion
Investigators have reported that the expression of Bcl-X L , but not Bcl-2 nor Bax, protein drops before the onset of CTLL-2 cell apoptosis (Broome et al., 1995) . We have con®rmed the decrease in Bcl-X L protein expression in CTLL-2 cells cultured without IL-2 (Figure 2) . However, the reason for the selective decrease in Bcl-X L protein expression during CTLL-2 cell apoptosis remains unknown. In the course of examining the expression of the Bcl-X L protein, we found two 18 kDa fragments that were recognized by an anti-mouse Bcl-X mAb (Figure 2 ). The expression of the 18 kDa fragments was also found in the CTLL-2 cell apoptosis induced by the anti-cancer drug VP-16 (Figure 3b ). The appearance of the 18 kDa fragments occurrred with dierent apoptotic stimuli. Although alternative splicing of bcl-X mRNA produces two distinct Bcl-X proteins (Bcl-X L and Bcl-X S ) (Boise et al., 1993) , we could not detect the expression of bcl-X S mRNA during CTLL-2 cell apoptosis (data not shown). Therefore, the 18 kDa fragments were not the Bcl-X S protein but the cleaved Bcl-X L fragments.
Mammalian caspases are homologues of ced-3, an apoptosis-related gene product in C. elegans. These caspases, such as caspase-1/ICE, caspase-2/Nedd-2/Ich-1, caspase-3/CPP32/Yama/Apopain, caspase-4/Ich-2/ TX/ICErel-II, caspase-5/ICErel-III/TY, caspase-6/ Mch-2 caspase-7/Mch-3/ICE-LAP3/CMH-1, caspase-8/FLICE/MACH/Mch-5, caspase-9/ICE-LAP6/Mch-6 and caspase-10/MCH-4, are important because their overexpression can induce apoptosis (Henkart, 1996) . Just as some potent inhibitors of caspases can suppress apoptosis induced by many stimuli (e.g., an anti-Fas mAb, tumor necrosis factor and anti-cancer drugs), these proteases are certainly involved in apoptotic signal transduction (Miura et al., 1993; Enari et al., 1995; Los et al., 1995; Mashima et al., 1995) . The substrates of these caspases not only included the caspases themselves but also poly(ADP-ribose) polymerase, actin, Gas2, DNA fragmentation factor, retinoblastoma protein, GDP-dissociation inhibitor type D4, DNA-dependent protein kinase, protein kinase Cd, and so on (Martin and Green, 1995; Villa et al., 1997) .
In CTLL-2 cell apoptosis, caspase-3/CPP32-like proteases, but not caspase-1/ICE-like proteases, were activated (Figure 4a and b) . We could not identify whether caspase-3/CPP32 was activated during CTLL-2 cell apoptosis because the anti-mouse caspase-3/ CPP32 antibody was not commercially available. However, caspase-3/CPP32 must certainly be activated during apoptosis because within the apoptosed CTLL-2 cell lysates there was protease activity that cleaved the substrates for caspase-3/CPP32, such as poly(ADPribose) polymerase (Nicholson et al., 1995) and actin (data not shown). Because several caspase inhibitors as well as the overexpression of human Bcl-2 could inhibit CTLL-2 cell apoptosis after IL-2 was withdrawn (Figures 4c and 5b) , caspase-3/CPP32-like proteases were involved in apoptosis promotion. Hence, we examined whether the cleavage of Bcl-X L protein was mediated by caspase-3/CPP32-like proteases. We found it was suppressed both by overexpressing human Bcl-2 protein and by adding several cell permeable caspase inhibitors in vivo (Figures 5d and 4d, respectively) . The cleavage was also suppressed by an inhibitor of caspase-3/CPP32-like proteases (DEVD-CHO) but not by an inhibitor of caspase-1/ICE-like proteases (YVAD-CHO) in vitro (Figure 6a ). Because Bcl-X L protein was cleaved by recombinant caspase-3/CPP32 (Figure 6b ), Bcl-X L protein is one of the substrates of caspase-3/CPP32. The Bcl-X L cleavage was a generally observed phenomena in cells undergoing apoptosis because Clem et al. (1998) have recently reported that Bcl-X L protein was also cleaved in cells induced to undergo apoptosis by IL-3 withdrawal or virus infection.
We found here that Bcl-X L protein but not Bcl-2 protein was cleaved during CTLL-2 cell apoptosis (Figure 2 ). Several investigators have recently reported that Bcl-2 protein was cleaved by caspase-3/CPP32 (Cheng et al., 1997; Grandgirard et al., 1998) . When the susceptibility to cleavage by caspase-3/CPP32 was compared, Bcl-X L protein (Figure 6b ) was more sensitive to caspase-3/CPP32 digestion than Bcl-2 protein (Figure 6c ). These results were consistent with the selective cleavage of Bcl-X L protein observed in CTLL-2 cells (Figure 2) .
Bcl-X L protein was recently reported to be cleaved between Asp 61 and Ser 62 by caspase-1/ICE and caspase-3/CPP32 (Clem et al., 1998) . We found another cleavage site in the loop domain (between Asp 76 and Ala
77
) that was associated with the production of A) contained Asp at the P1 position that were preferentially recognized by caspases (Talanian et al., 1997; Thornberry et al., 1997) . However, the cleavage site was very unique because it had His or Ser at the P4 position. Since caspase-3/CPP32 preferentially cleaved the substrate that contained Asp at the both P1 and P4 positions (P4 to P1; DXXD in which X may be any amino acid) (Talanian et al., 1997; Thornberry et al., 1997) , caspases other than caspase-3/CPP32 might also be involved in cleavage of the Bcl-X L protein in vivo.
When Bcl-X L protein was cleaved between Asp 61 and Ser 62 or between Asp 76 and Ala 77 in the loop domain, Bcl-X L protein lost the fourth region of Bcl-2 homology (BH4) domain, which was conserved among death-antagonistic Bcl-2 family proteins ( Figure 9 ) (Kroemer, 1997) . The BH4 domain is lacking in the Bax-like death agonists, with the exception of Bcl-X S . In Bcl-2 protein, the BH4 domain was not required for heterodimerization with death agonists, such as Bax (Hanada et al., 1995) . However, the loss of the BH4 domain resulted in a markedly impaired ability to suppress apoptosis (Hanada et al., 1995) . Recently, the three-dimensional structure of the Bcl-X L protein revealed the loop domain between BH4 and BH3 domains (Muchmore et al., 1996) . Although this domain was not conserved between Bcl-X L and Bcl-2, the loop deletion mutants of Bcl-X L and Bcl-2 exhibited increased death-antagonistic eects (Chang et al., 1997) . As Bcl-X L protein was cleaved at the loop domain, we tested the death-regulating activities of the NH 2 terminal-truncated form of the Bcl-X L protein (DN-Bcl-X L ). Expression of the DN-Bcl-X L protein in 293T cells resulted in increased sensitivity to apoptosis induced by VP-16 (Figure 8c) . Therefore, the Bcl-X L protein cleavage by caspases accelerated apoptotic cell death not only by decreasing the expression level of the death-antagonistic Bcl-X L protein but also by increasing the expression level of the death-agonistic 18 kDa Bcl-X L fragments (Figure 9 ). Several investigators have reported the loss of Bcl-X L protein expression during apoptosis in some cell lines; however, further information on the fate of the Bcl-X L protein has not yet been reported (Broome et al., 1995; Lotem and Sachs, 1995; Benito et al., 1997; Frankel et al., 1997; Hsu et al., 1997; Leverrier et al., 1997) . Since the cleavage sites in bcl-X L were identical in mouse and human, the Bcl-X L protein would be cleaved and the resulting 18 kDa Bcl-X L fragments would accelerate apoptotic cell death in these cell lines.
Xue and Horvitz (1997) revealed that the C. elegans death antagonist CED-9 protein was cleaved by CED-3 protease. CED-9 protein might inhibit CED-3 protease both by functioning as a competitive inhibitor of caspases and by unknown death-antagonistic mechanisms that were mediated by the BH1 domain in CED-9 (Xue and Horvitz, 1997) . Bcl-X L protein suppressed programmed cell death in mammalian cells through mechanisms similar to CED-9 because (1) neither the cleavage site mutation nor the BH1 domain mutation impaired the death-antagonistic eects and (2) the combination of these mutations abolished the deathantagonistic eects of Bcl-X L protein (Clem et al., 1998) . However, the cleaved Bcl-X L fragment exhibited the death-agonistic eects, while the cleaved CED-9 fragment retained the death-antagonistic eects (Xue and Horvitz, 1997) . As the CED-3 protease cleaved CED-9 between NH 2 terminal and BH4 domain, the cleaved CED-9 fragment contained the anti-apoptotic BH4 domain. Thus, the cleaved CED-9 fragment retains the death-antagonistic eects.
Finally, we found the cleavage of Bcl-X L protein by caspase-3/CPP32-like proteases during CTLL-2 cell apoptosis. The resultant Bcl-X L cleaved fragments are structually and functionally similar to the Bax-like death agonist (Kroemer, 1997) because they lack the BH4 domain and promote apoptotic cell death. Therefore, caspase-3/CPP32-like proteases may regulate apoptotic cell death by converting the deathantagonistic Bcl-2 family proteins to death agonists.
Materials and methods

Cell culture conditions
A murine IL-2-dependent T cell clone CTLL-2 was obtained from Japanese Cancer Cell Resources Bank (JCRB, Saitama, Japan) and cultured at 378C in a humidi®ed atmosphere of 5% CO 2 and 95% air in RPMI 1640 medium (Nissui Pharmaceutical Co., Tokyo, Japan) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Biocell, Carson, CA), 2 mM L-glutamine (Gibco Laboratories, Grand Island, NY), 100 mg/ml of kanamycin, and 20 U/ml of recombinant mouse IL-2 (Genzyme, Cambridge, MA) (IL-2-supplemented medium). 293T cells were cultured in Dulbecco's modi®ed Eagle's medium (Nissui), supplemented with 10% heatinactivated FBS at 378C in a humidi®ed atmosphere of 5% CO 2 and 95% air.
Estimation of apoptosis in CTLL-2 cells
CTLL-2 cells (2610 5 cells/ml) were incubated with or without IL-2 (20 U/ml). In some experiments, VP-16 (etoposide; 10 mg/ml; kindly provided by Bristol MeyersSquibb, Tokyo, Japan), Z-Asp-CH 2 -DCB (Funakoshi, Tokyo, Japan), Z-VAD-CH 2 -DCB (Funakoshi), and Z-EVD-CH 2 -DCB (Funakoshi) were added to the culture medium. The DNA of these cells was separated and electrophoresed in a 2% agarose gel plate, as described previously (Fujita et al., 1993) . Morphological features were examined by ®xing CTLL-2 cells with methanol/ acetate (3 : 1). The ®xed cells were applied to slide glass and stained with DAPI (1 mg/ml) for 30 min in the dark. The nuclear fragmentations were visualized by using ā uorescence microscope equipped with a UV-2A ®lter, as described previously (Noguchi et al., 1996) . In some experiments, viable cell numbers were counted using the trypan blue dye exclusion method.
Expression vector construction
An EcoRI ± EcoRI fragment of human bcl-2 cDNA (kindly provided from Dr Y Tsujimoto of Osaka University, Osaka, Japan) (Tsujimoto et al., 1985) was cloned into a pcDNA3 vector (Invitrogen, San Diego, CA). Murine bcl-X L and bcl-2 cDNAs were generated by RT ± PCR with CTLL-2 mRNA as the template. The sense and antisense primers for mouse bcl-X L were 5'-TGGACAATG-GACTGGTTGAG-3' and 5'-AGTGTCTGGTCACTTCCCleavage of Bcl-X L during apoptosis N Fujita et al GAC-3', respectively. The sense and antisense primers for mouse bcl-2 were 5'-CAGCTTCTTTTCGGGGAAGG-3' and 5'-AGGTTTGTCGACCTCACTTG-3', respectively. The PCR products were cloned into a pCRII vector (Invitrogen). Substitutions of aspartic acid at 61, 76, 95 and 107 with alanine (D61A, D76A, D95A and D107A, respectively) in bcl-X L were accomplished by converting the aspartic acid codon GAT to alanine codon GCT by PCR mutagenesis using the QuickChange site-directed mutagenesis kit (Stratagene, La Jolla, CA). The translation initiation codon ATG in some cDNAs was converted to isoleucine codon ATC to permit fusion with the Xpress epitope (DLYDDDDK) at the 5' end. The NH 2 terminaltruncated form of mouse bcl-X L cDNAs (DN-bcl-X L ; amino acids 62 ± 233) were generated by PCR using the sense (5'-CTAGCCCGGCCGTGAATGGAG-3') and antisense (5'-AGTGTCTGGTCACTTCCGAC-3') primers. The PCR products were cloned into a pCRII vector (Invitrogen) and then fused with Xpress epitope containing the translation initiation codon ATG at the 5' end. All these cDNAs were used as templates in a double-stranded sequanase reaction before subcloning (Amersham, Cleveland, Ohio), using SP6 and T7 promoters as primers. These cDNAs were then cut with EcoRI (a site within the pCRII vector), to release EcoRI ± EcoRI fragments, and were subcloned into an EcoRI site of the pcDNA3 vector (Invitrogen).
Stable and transient transfection
Ten micrograms of human bcl-2 cDNA in a pcDNA3 vector or pcDNA3 vector alone were transfected into 10 6 CTLL-2 cells by electroporation using a Bio-Rad Gene Pulser (Bio-Rad, Hercules, CA) at 220 V, 960 mF. Transfectants were selected in IL-2-supplemented medium containing 800 mg/ml of G418 antibiotics (Gibco). Several G418-resistant clones were screened by Western blot analysis, as described below using an anti-human Bcl-2-speci®c mAb (clone 124; Boehringer Mannheim, Mannheim, Germany).
To examine the eect of the NH 2 terminal-truncated form of mouse Bcl-X L protein in apoptosis progression, 3 mg of Xpress epitope-tagged DN-bcl-X L cDNA or Xpress epitopetagged wild-type bcl-X L cDNA in pcDNA3 vector were transiently transfected into 293T cells using Superfect transfection reagent according to the manufacturer's instruction (Qiagen, Hilden, Germany). After cultivation for 24 h, cells were treated with 20 mg/ml of VP-16. The cells were cultured for an additional 24 h and harvested. The apoptosed 293T cells were detected using an Annexin-V-¯uos staining kit, according to the manufacturer's instruction (Boehringer Mannheim). The expression of DN-Bcl-X L and wild-type Bcl-X L proteins were con®rmed by Western blot analysis, as described below using an anti-mouse Bcl-X L&S -speci®c mAb (#B22620; Transduction Laboratories, Lexington, KY).
Western blot analysis
Western blot analysis was performed as described previously (Lee et al., 1996) with a slight modi®cation. In brief, cells were solubilized with lysis buer containing 2% Nonidet P-40 and 0.2% SDS under reduced conditions. Then the cell lysates (20 mg/lane) were applied to a 10 ± 20% gradient polyacrylamide gel. The electrophoresed proteins were transblotted onto a nitrocellulose membrane. After blocking, the membranes were incubated with an anti-mouse Bcl-2-speci®c mAb (Pharmingen, San Diego, CA), an anti-mouse Bcl-X L&S -speci®c mAb (Transduction), an anti-Bax polyclonal antibody (pAb) (Upstate Biotechnology, Lake Placid, NY), an anti-mouse Bag-1-speci®c pAb (Santa Cruz Biotechnology, Santa Cruz, CA), and an anti-Xpress mAb (Invitrogen). The membrane was then incubated with peroxidase-conjugated second antibody, followed by developing with enhanced chemilluminescence (ECL) mixture (Amersham, Buckinghamshire, United Kingdom).
Measurement of caspase activity
The caspase activity in the cell lysate was measured as previously described (Lee et al., 1996) with slight modi®cations. In brief, cells were harvested and lysed with lysis buer (10 mM HEPES (pH 7.4), 2 mM EDTA, 0.1% CHAPS, and 5 mM dithiothreitol). The cell lysate (5 mg) was then incubated with 20 mM of YVAD-AMC (Peptide Institute, Osaka, Japan) or DEVD-AMC (Peptide Institute) in ICE buer (20 mM HEPES (pH 7.4), 10% glycerol, and 2 mM dithiothreitol) for 1 h at 378C. The AMC released from the¯uorogenic substrates was excited at 380 nm, and the emission was measured at 460 nm using a Hitachi¯uorescence spectrophotometer, model F-2000 (Hitachi, Tokyo, Japan).
Cleavage assay
To prepare apoptosed CTLL-2 cell lysates, the cells were incubated for 24 h in IL-2-depleted medium. The cytosol fraction of CTLL-2 cells were prepared, as described previously . In brief, the cells were quickly frozen at 7808C and thawed on ice-water three times. The samples were centrifuged (100 000 g) for 1 h at 48C. The supernatant was collected and used as the cytosol fraction. Then the Xpress epitope-tagged wild-type mouse Bcl-X L , Xpress epitope-tagged mutant mouse Bcl-X L , and wild-type mouse Bcl-2 proteins were labeled with 35 Smethionine using a rabbit reticulocyte lysate system (TNT T7 quick coupled transcription/translation system; Promega, Madison, WI). The translated reticulocyte lysate (2 ml) was incubated with the apoptosed CTLL-2 cytosol fractions (25 mg) or active recombinant human caspase-3/ CPP32 (Pharmingen) in ICE buer for 4 h at 378C. In some experiments, YVAD-CHO (Peptide Institute), DEVD-CHO (Peptide Institute), and aprotinin (Sigma Chemical Co., St. Louis, MO) were added to the reactions. The reactions were applied to a 15 ± 25% gradient polyaerylamide gel, followed by autoradiography.
